BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,952 Cr | ₹-180 Cr | ₹3,823 Cr | ₹4,554 Cr | ₹3,390 Cr |
What is the latest Net Current Assets ratio of BIOCON ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,952 Cr |
| Mar2024 | ₹-180 Cr |
| Mar2023 | ₹3,823 Cr |
| Mar2022 | ₹4,554 Cr |
| Mar2021 | ₹3,390 Cr |
How is Net Current Assets of BIOCON Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,952 Cr | Positive | |
| Mar2024 | ₹-180 Cr | Negative | |
| Mar2023 | ₹3,823 Cr | -16.05 | |
| Mar2022 | ₹4,554 Cr | 34.33 | |
| Mar2021 | ₹3,390 Cr | - | |
Compare Net Current Assets of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹69,739.2 Cr | 1% | 20.3% | 26.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 1% |
20.3% |
26.2% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses